Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...
The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue ...